SIR -I was pleased to read your News Feature "The brains trust of Tehran" (Nature 435, 264-265; 2005) , which reminded me, and probably many young Iranian scientists raised after the revolution, of our enthusiasm for scientific research at university, despite access to only the most basic of equipment.
It is disappointing for me to see the effects that the sanctions imposed on Iran by the United States are having on basic biomedical research. In the example cited in your News Feature it took four years for the Iranian lab to secure equipment for neuronal recordings. I understand that the United States would not welcome scientific achievements in fields such as nuclear science or space technology for fear that they could be used to make weapons of mass destruction. But I believe other scientific fields, especially biomedical ones, should be exempt from these sanctions.
Local research on endemic diseases such as haemophilias, thalassaemias and oesophageal carcinoma may lead to new preventive and therapeutic insights beneficial to patients in Iran and worldwide; sanctions should not apply to this kind of work. I do not think it is difficult to differentiate such activities from those used to further geopolitical and governmental goals, and I would like to see the US government reconsider some of its scientific embargos against Iran. Bioterror killed five in US; guns kill 30,000 a year SIR -I read with concern the call for biological scientists to be more careful in how they communicate their work ("Biologists asked to breed a culture of responsibility in face of terrorism" Nature 435, 860; 2005). Many implements can be used by terrorists to harm people, by far the most common being military-style firearms. Every year in the United States, some 30,000 people are killed by firearms. The only lethal biological attack in the United States was carried out in 2001, using a supply of anthrax that came from a US source and killed five people.
In the United States, every call to restrict access to military-style firearms by civilians is met with fierce opposition from the National Rifle Association (NRA), who proclaim that the Second Amendment prevents any such regulation. When the number of people killed by biological agents gleaned from the scientific literature exceeds the number killed by firearms, perhaps then we should consider restricting that literature in the same way that firearms are restricted. Until then, we should be prepared to uphold the First Amendment and protect the freedom of speech.
To Ethics debate is what put Newcastle paper in the news SIR -Your Editorial "Too much, too soon" (Nature 435, 538; 2005) deplored the fact that the abstract for our manuscript submitted to Reproductive BioMedicine (RBM) Online became public, before being peer-reviewed, on the same day that a Korean group led by W. S. Hwang announced in a Science paper that it had succeeded in producing eleven embryonic stem-cell lines. We would like to clarify our position in this matter.
On 16 May, we submitted a manuscript to RBM Online that had previously been offered to both the British Medical Journal and The Lancet; both journals had declined it after editorial review, claiming insufficient clinical content. At the time of submission to RBM Online, we were not aware that the abstract would be made immediately available online. Learning of this the next day, we asked RBM Online to remove the abstract to prevent public awareness before publication of the Science study. One of us also met Professor Hwang to inform him of our actions and exchange manuscripts. Our paper has now been accepted for publication by RBM Online and will appear, in full, in August.
On 16 May, UK journalists also became aware of the forthcoming publication in Science and contacted us to ask about our progress with nuclear transfer. We did not comment on the Korean breakthrough in advance of its publication, but felt it natural and necessary to say that we had submitted our work and that it would soon become public. In our subsequent comments, we were very clear that the Koreans had made a major advance, when compared with our own achievement.
We believe the strong interest in our work was not driven primarily by a parochialism that affords prominence to local news, but by the ongoing ethical debate. It is the ethics of human nuclear transfer that keeps embryo research high on the agenda of the UK press and public, not the science. We cannot avoid the resulting close and continuous scrutiny, nor should we. 
